Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

2017: 9 Groundbreaking Developments Achieved with CRISPR

2017: 9 Groundbreaking Developments Achieved with CRISPR

Regarded as one of the century’s most important discoveries, CRISPR/CAS9 genetic technology led to groundbreaking medical developments in 2017. Let us explore these studies together.

Video: What Is Crispr?

1.Crispr Became More Precise and Safer

Crispr performs gene editing in DNAby creating double-strand breaks. However, in some cases, Crispr targets other gene regions, causing abnormalities in the genome. When first developed, Crispr only allowed editing of the entire gene. A method developed in 2017 made it possible to alter a single nucleotide (the basic building block of DNA) in a gene. This offers great hope, particularly for treating genetic diseases. Single-nucleotide mutationsaccount for half of the 32 mutations known to be associated with human diseases.

2.Crispr Performed Gene Editing in a Human Embryo for the First Time

Researchers in the United States successfully performed genetic editing in embryos for the first time. Crispr was used to genetically edit embryos carrying a fatal inherited heart condition. The disease-causing mutation was eliminated in a large proportion of the embryos.

3.A Crispr Treatment Against Huntington Disease Was Developed

Huntington disease, also known as Huntington chorea, results from toxic protein accumulation in the brain and is caused by mutations in the huntingtin gene. An effective treatment method using crispr was successfully developed against this fatal neurological disease, which has no treatment and is inherited from a mother or father. Researchers managed to eliminate these mutations to a large extent in mice with Huntington disease. After 3 weeks, a reduction in toxic proteins in the mice’s brains was observed. This study will also provide important guidance for developing similar treatments against other neurological diseases.

4. A Gene Editing Method Began to Be Tested in a Patient for the First Time

In the United States, a 44-year-old patient began receiving gene editing treatment for the first time. The therapy uses the Talen method, which is similar to crispr technology. Researchers aimed to correct mutations in a patient with a rare metabolic disease. The same research group is working on a gene editing method intended to eliminate HIV.

5. The First Semisynthetic Bacterium Was Developed with Crispr

Researchers designed a bacterium containing different nucleotides using Crispr genetic technology. Alongside the usual 4 types of nucleotides, the semisynthetic bacterium contains 2 new nucleotides. The bacteria developed in the study were observed not to pose any safety hazard.

6. Crispr Enabled Antibiotic-Resistant Bacteria to Destroy Themselves

By adding an antibiotic-resistance gene sequence to viruses, bacteria were made to destroy themselves. This development offers an effective treatment possibility against antibiotic-resistant bacteria, which cause substantial loss of life. Pills containing the CRISPR/CAS9 system may replace antibiotics in the future.

7. Tumor Growth Was Stopped by Using Crispr to Target Fusion Mutations Frequently Seen in Cancer

Mutations resulting from the fusion of two genes are common in cancer. Using a method resembling cut and paste, substantial tumor shrinkage was observed in mouse models of prostate and liver cancer.

8. Cancer Cell Growth Was Slowed with Crispr

Researchers managed to reduce the growth rate of rapidly growing tumors by targeting TUDOR-SN, an important gene in cancer cell proliferation. This method may pave the way for effective cancer treatments.

9. Crispr-Modified Pigs Paved the Way for Their Use in Human Organ Transplants

The main problem in human organ transplantation is a shortage of donors. In recent years, the idea of transplanting organs from animals such as pigs into humans has gained prominence. However, some viruses in pigs could be transferred with the organ, risking serious diseases in humans. Researchers successfully eliminated these viruses by using Crispr to intervene in pig embryos. All 37 genetically modified pigs were healthy and free of the viruses. This development will enable pigs to be used in human organ transplantation.

Sources

1. Gaudelli NM, Komor AC, Rees HA ve ark.
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.
Nature. 2017

2. Niu D, Wei HJ, Lin L ve ark.
Yang L. Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9.
Science. 2017

3. Su Yang, Shihua Li, Xiao-Jiang Li.
CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease.
J Clin Invest. 2017

4. Chen ZH, Yu YP, Zuo ZH ve ark.
Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene.
Nat Biotechnol. 2017

5. Elbarbary, Reyad A. et al.
Tudor-SN-Mediated Endonucleolytic Decay of Human-Cell microRNAs Promotes G1/S Phase Transition.
Science 2017

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

2017: 9 Groundbreaking Developments Achieved with CRISPR

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy